Vixiar, a Johns Hopkins spinout marketing a tablet-based point of care system for assessing cardiac filling pressure, has raised $1.5 million in Series A funding. This brings the company’s total funding to $3 million.
New investors Emerald Development Managers and MMG Opportunities contributed to the round, along with existing investor The Maryland Technology Development Corporation (TEDCO),...
